|Slideshows|March 10, 2017

Lessons in Mitigating Violence

Strategies to reduce aggression in psychiatric treatment settings.

View the slides in PDF format. Also see: Violence in Bipolar Disorder.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

ByLeah Kuntz

May 26th 2026

Childbirth-Related PTSD: Recognizing and Assessing This Unique Subtype

ByAmanda Koire, MD, PhD

May 18th 2026

Premature Mortality in Schizophrenia: What Clinicians Can Do

ByFaith Dickerson, PhD, MPH

May 18th 2026

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

ByJames Rachal, MD

May 16th 2026

Examining Ethnoracial Disparities in the Prevalence of Schizophrenia Spectrum Disorders

ByLeah Kuntz,Mark Olfson, MD, MPH

May 15th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Lessons in Mitigating Violence

Related Content

FDA Grants De Novo Approval to Modius Spero, Neuromodulation Device for PTSD

Childbirth-Related PTSD: Recognizing and Assessing This Unique Subtype

Premature Mortality in Schizophrenia: What Clinicians Can Do

Intimate Partner Violence and Psychiatric Leadership: Clinical Perspectives

Examining Ethnoracial Disparities in the Prevalence of Schizophrenia Spectrum Disorders

Latest CME

Southern California Psychiatry Conference

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

“Engineered Addiction”: Redefining Addictive Disorders and the Psychiatric Impact of Social Media

Predicting Relapse in Treatment-Resistant Depression: Findings From New Esketamine Analysis

Podcast: Early Intervention & Psychopharmacology in Bipolar Disorder With Robert M. Post, MD

Paying Attention to the Psychopharmacology Pipeline

AI-Driven Biomarker Discovery from Wearables in Neuropsychiatric Research